Patents by Inventor Laurent Chantalat

Laurent Chantalat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • UV device for smartphone-based evaluation of skin conditions
    Patent number: 11375946
    Abstract: A method for evaluating skin conditions on a skin area of a user using an ultraviolet light device that can connect to a mobile device and a user input is disclosed. The method for evaluating skin conditions includes the steps of illuminating the skin area of the user with the ultraviolet light device operated by the mobile device, capturing an image of the illuminated skin area with an image capture device, processing the image with a processing program to determine the level of fluorescence on the skin area, and mapping progress of treatment of the skin condition based on the processed image compared to a control image.
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: July 5, 2022
    Assignee: GALDERMA RESEARCH AND DEVELOPMENT
    Inventors: Laurent Petit, Laurent Chantalat
  • Pharmaceutical composition comprising refined indigo naturalis extracts and the use thereof
    Patent number: 11116811
    Abstract: A refined Indigo Naturalis extract or Indigo-producing plant extract containing at least 65% (w/w) an indirubin derivative based on total weight of active ingredients is described. Also described are a pharmaceutical composition containing the refined extract, and the use of the pharmaceutical composition for treating or alleviating a disease or condition.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: September 14, 2021
    Assignee: Galderma S.A.
    Inventors: Laurent Chantalat, Philippe Andres
  • Extract from Indigo Naturalis and a process for preparing the same
    Patent number: 10695391
    Abstract: The present invention relates to a process for preparing an extract from one or more botanical raw materials, such as Indigo Naturalis and the extract itself. The present invention also relates to a composition comprising the extract, as well as the use of composition in medical or cosmetic applications.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: June 30, 2020
    Assignee: Galderma S.A.
    Inventors: Yin-Ku Lin, Isabelle Cardinaud, Philippe Andres, Laurent Chantalat, Jean-Thomas Pierson, Antoine Bily, Loïc Le Bronec
  • Antibacterial indigo naturalis or indigo-producing plant extract and use thereof
    Patent number: 10668120
    Abstract: A pharmaceutical or cosmetic composition is provided. The composition includes an Indigo Naturalis or Indigo-producing plant extract, for inhibiting Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus. A method of inhibiting Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, is also provided. The method includes contacting a cell with an effective amount of an Indigo Naturalis or Indigo-producing plant extract.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: June 2, 2020
    Assignee: Galderma SA
    Inventors: Yin-Ku Lin, Philippe Andres, Laurent Chantalat
  • PHARMACEUTICAL COMPOSITION COMPRISING REFINED INDIGO NATURALIS EXTRACTS AND THE USE THEREOF
    Publication number: 20200147163
    Abstract: A refined Indigo Naturalis extract or Indigo-producing plant extract containing at least 65% (w/w) an indirubin derivative based on total weight of active ingredients is described. Also described are a pharmaceutical composition containing the refined extract, and the use of the pharmaceutical composition for treating or alleviating a disease or condition.
    Type: Application
    Filed: January 17, 2020
    Publication date: May 14, 2020
    Inventors: Laurent CHANTALAT, Philippe ANDRES
  • Pharmaceutical composition comprising refined extracts and the use thereof
    Patent number: 10555985
    Abstract: A refined Indigo Naturalis extract or Indigo-producing plant extract containing at least 65% (w/w) an indirubin derivative based on total weight of active ingredients is described. Also described are a pharmaceutical composition containing the refined extract, and the use of the pharmaceutical composition for treating or alleviating a disease or condition.
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: February 11, 2020
    Assignee: Galderma S.A.
    Inventors: Laurent Chantalat, Philippe Andres
  • Pharmaceutical composition comprising refined extracts and the use thereof
    Patent number: 10525095
    Abstract: A refined Indigo Naturalis extract or Indigo-producing plant extract containing at least 65% (w/w) an indirubin derivative based on total weight of active ingredients is described. Also described are a pharmaceutical composition containing the refined extract, and the use of the pharmaceutical composition for treating or alleviating a disease or condition.
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: January 7, 2020
    Assignee: Galderma S.A.
    Inventors: Laurent Chantalat, Philippe Andres
  • EXTRACT FROM INDIGO NATURALIS AND A PROCESS FOR PREPARING THE SAME
    Publication number: 20190224264
    Abstract: The present invention relates to a process for preparing an extract from one or more botanical raw materials, such as Indigo Naturalis and the extract itself. The present invention also relates to a composition comprising the extract, as well as the use of composition in medical or cosmetic applications.
    Type: Application
    Filed: March 28, 2019
    Publication date: July 25, 2019
    Inventors: Yin-Ku Lin, Isabelle Cardinaud, Philippe Andres, Laurent Chantalat, Jean-Thomas Pierson, Antoine Bily, Loïc Le Bronec
  • UV DEVICE FOR SMARTPHONE-BASED EVALUATION OF SKIN CONDITIONS
    Publication number: 20190183416
    Abstract: A method for evaluating skin conditions on a skin area of a user using an ultraviolet light device that can connect to a mobile device and a user input is disclosed. The method for evaluating skin conditions includes the steps of illuminating the skin area of the user with the ultraviolet light device operated by the mobile device, capturing an image of the illuminated skin area with an image capture device, processing the image with a processing program to determine the level of fluorescence on the skin area, and mapping progress of treatment of the skin condition based on the processed image compared to a control image.
    Type: Application
    Filed: August 17, 2017
    Publication date: June 20, 2019
    Applicant: GALDERMA RESEARCH AND DEVELOPMENT
    Inventors: Laurent PETIT, Laurent CHANTALAT
  • PHARMACEUTICAL COMPOSITION COMPRISING REFINED INDIGO NATURALIS EXTRACTS AND THE USE THEREOF
    Publication number: 20190160128
    Abstract: A refined Indigo Naturalis extract or Indigo-producing plant extract containing at least 65% (w/w) an indirubin derivative based on total weight of active ingredients is described. Also described are a pharmaceutical composition containing the refined extract, and the use of the pharmaceutical composition for treating or alleviating a disease or condition.
    Type: Application
    Filed: January 30, 2019
    Publication date: May 30, 2019
    Inventors: Laurent CHANTALAT, Philippe ANDRES
  • Extract from indigo naturalis and a process for preparing the same
    Patent number: 10251926
    Abstract: The present invention relates to a process for preparing an extract from one or more botanical raw materials, such as Indigo Naturalis and the extract itself. The present invention also relates to a composition comprising the extract, as well as the use of composition in medical or cosmetic applications.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: April 9, 2019
    Assignee: Galderma S.A.
    Inventors: Yin-Ku Lin, Isabelle Cardinaud, Philippe Andres, Laurent Chantalat, Jean-Thomas Pierson, Antoine Bily, Loïc Le Bronec
  • Pharmaceutical composition comprising refined indigo naturalis extract and the use thereof
    Patent number: 10232006
    Abstract: A refined Indigo Naturalis extract or Indigo-producing plant extract containing at least 65% (w/w) an indirubin derivative based on total weight of active ingredients is described. Also described are a pharmaceutical composition containing the refined extract, and the use of the pharmaceutical composition for treating or alleviating a disease or condition.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: March 19, 2019
    Assignee: Galderma S.A.
    Inventors: Laurent Chantalat, Philippe Andres
  • ANTIBACTERIAL INDIGO NATURALIS OR INDIGO-PRODUCING PLANT EXTRACT AND USE THEREOF
    Publication number: 20180110819
    Abstract: A pharmaceutical or cosmetic composition is provided. The composition includes an Indigo Naturalis or Indigo-producing plant extract, for inhibiting Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus. A method of inhibiting Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, is also provided. The method includes contacting a cell with an effective amount of an Indigo Naturalis or Indigo-producing plant extract.
    Type: Application
    Filed: April 8, 2016
    Publication date: April 26, 2018
    Inventors: Yin-Ku LIN, Philippe ANDRES, Laurent CHANTALAT
  • EXTRACT FROM INDIGO NATURALIS AND A PROCESS FOR PREPARING THE SAME
    Publication number: 20180099020
    Abstract: The present invention relates to a process for preparing an extract from one or more botanical raw materials, such as Indigo Naturalis and the extract itself. The present invention also relates to a composition comprising the extract, as well as the use of composition in medical or cosmetic applications.
    Type: Application
    Filed: December 13, 2017
    Publication date: April 12, 2018
    Inventors: Yin-Ku LIN, Isabelle CARDINAUD, Philippe ANDRES, Laurent CHANTALAT, Jean-Thomas PIERSON, Antoine BILY, Loïc LE BRONEC
  • Extract from indigo naturalis and a process for preparing the same
    Patent number: 9861673
    Abstract: The present invention relates to a process for preparing an extract from one or more botanical raw materials, such as Indigo Naturalis and the extract itself. The present invention also relates to a composition comprising the extract, as well as the use of composition in medical or cosmetic applications.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: January 9, 2018
    Assignee: Galderma S.A.
    Inventors: Yin-Ku Lin, Isabelle Cardinaud, Philippe Andres, Laurent Chantalat, Jean-Thomas Pierson, Antoine Bily, Loïc Le Bronec
  • Treatment of atopic dermatitis with indigo naturalis or indigo producing plant extract
    Patent number: 9833438
    Abstract: A pharmaceutical or cosmetic composition comprising an Indigo Naturalis or Indigo-producing plant extract for treating atopic dermatitis and any form of eczema, and a method of treating atopic dermatitis comprising administering a therapeutically effective amount of an Indigo Naturalis or Indigo-producing plant extract to a subject in need thereof are described.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: December 5, 2017
    Assignee: Galderma S.A.
    Inventors: Philippe Andres, Laurent Chantalat, Yin-Ku Lin
  • PHARMACEUTICAL COMPOSITION AND THE USE THEREOF
    Publication number: 20170304381
    Abstract: A pharmaceutical composition, as well as the use of composition in medical applications, are described.
    Type: Application
    Filed: May 11, 2017
    Publication date: October 26, 2017
    Inventors: Laurent CHANTALAT, Philippe ANDRES
  • TREATMENT OF ATOPIC DERMATITIS WITH INDIGO NATURALIS OR INDIGO PRODUCING PLANT EXTRACT
    Publication number: 20170290804
    Abstract: A pharmaceutical or cosmetic composition comprising an Indigo Naturalis or Indigo-producing plant extract for treating atopic dermatitis and any form of eczema, and a method of treating atopic dermatitis comprising administering a therapeutically effective amount of an Indigo Naturalis or Indigo-producing plant extract to a subject in need thereof are described.
    Type: Application
    Filed: June 27, 2017
    Publication date: October 12, 2017
    Inventors: Philippe ANDRES, Laurent CHANTALAT, Yin-Ku LIN
  • EXTRACT FROM INDIGO NATURALIS AND A PROCESS FOR PREPARING THE SAME
    Publication number: 20170266248
    Abstract: The present invention relates to a process for preparing an extract from one or more botanical raw materials, such as Indigo Naturalis and the extract itself. The present invention also relates to a composition comprising the extract, as well as the use of composition in medical or cosmetic applications.
    Type: Application
    Filed: May 11, 2017
    Publication date: September 21, 2017
    Inventors: Yin-Ku LIN, Isabelle CARDINAUD, Philippe ANDRES, Laurent CHANTALAT, Jean-Thomas PIERSON, Antoine BILY, Loïc LE BRONEC
  • NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS
    Publication number: 20160280650
    Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.
    Type: Application
    Filed: June 3, 2016
    Publication date: September 29, 2016
    Inventors: Laurence CLARY, Sandrine CHAMBON, Laurent CHANTALAT, Carine ROSIGNOLI, Olivier ROYE, Jean-Claude PASCAL, Marlene SCHUPPLI-NOLLET